Literature DB >> 9368759

The importin-beta family member Crm1p bridges the interaction between Rev and the nuclear pore complex during nuclear export.

M Neville1, F Stutz, L Lee, L I Davis, M Rosbash.   

Abstract

BACKGROUND: The human immunodeficiency virus (HIV-1) uses the viral protein Rev to regulate gene expression by promoting the export of unspliced and partially spliced viral transcripts. Rev has been shown to function in a variety of organisms, including Saccharomyces cerevisiae. The export activity of Rev depends on a nuclear export signal (NES), which is believed to interact either directly or indirectly with the nuclear pore complex to carry out its export function. Crm1p is a member of the importin-beta protein family, other members of which are known to be directly involved in nuclear import. Crm1p has recently been shown to contribute to nuclear export in vertebrate systems. Here, we have studied this mechanism of nuclear to cytoplasmic transport.
RESULTS: Viable mis-sense mutations in the CRM1 gene substantially reduced or eliminated the biological activity of Rev in S. cerevisiae, providing strong evidence that Crm1p also contributes to transport of Rev NES-containing proteins and ribonucleoproteins in this organism. Crm1p interacted with FG-repeat-containing nuclear pore proteins as well as Rev, and we have demonstrated that the previously described two-hybrid interaction between Rev and the yeast nuclear pore protein Rip1p is dependent on wild-type Crm1p.
CONCLUSIONS: We conclude that Crm1p interacts with the Rev NES and nuclear pore proteins during delivery of cargo to the nuclear pore complex. Our findings also agree well with current experiments on Crm1p orthologs in Schizosaccharomyces pombe and in vertebrate systems.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9368759     DOI: 10.1016/s0960-9822(06)00335-6

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  210 in total

1.  cORF and RcRE, the Rev/Rex and RRE/RxRE homologues of the human endogenous retrovirus family HTDV/HERV-K.

Authors:  C Magin; R Löwer; J Löwer
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

Review 2.  Nuclear RNA export pathways.

Authors:  B R Cullen
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

3.  Analysis of cellular factors that mediate nuclear export of RNAs bearing the Mason-Pfizer monkey virus constitutive transport element.

Authors:  Y Kang; H P Bogerd; B R Cullen
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

4.  Role of the influenza virus M1 protein in nuclear export of viral ribonucleoproteins.

Authors:  M Bui; E G Wills; A Helenius; G R Whittaker
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Cytoplasmic sequestration of rel proteins by IkappaBalpha requires CRM1-dependent nuclear export.

Authors:  W F Tam; L H Lee; L Davis; R Sen
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

6.  Splicing is required for rapid and efficient mRNA export in metazoans.

Authors:  M J Luo; R Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

7.  Purification of the vertebrate nuclear pore complex by biochemical criteria.

Authors:  B R Miller; D J Forbes
Journal:  Traffic       Date:  2000-12       Impact factor: 6.215

8.  The carboxyl terminus of RNA helicase A contains a bidirectional nuclear transport domain.

Authors:  H Tang; D McDonald; T Middlesworth; T J Hope; F Wong-Staal
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

9.  Formation of Tap/NXT1 heterodimers activates Tap-dependent nuclear mRNA export by enhancing recruitment to nuclear pore complexes.

Authors:  Heather L Wiegand; Glen A Coburn; Yan Zeng; Yibin Kang; Hal P Bogerd; Bryan R Cullen
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

10.  Protein ligands mediate the CRM1-dependent export of HuR in response to heat shock.

Authors:  I E Gallouzi; C M Brennan; J A Steitz
Journal:  RNA       Date:  2001-09       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.